Planta Med 2002; 68(9): 847-850
DOI: 10.1055/s-2002-34400
Letter
© Georg Thieme Verlag Stuttgart · New York

Effects of Chronic Chrysin Treatment in Spontaneously Hypertensive Rats

Inmaculada Concepción Villar1 , Rosario Jiménez1 , Milagros Galisteo1 , Maria Francisca Garcia-Saura1 , Antonio Zarzuelo1 , Juan Duarte1
  • 1Department of Pharmacology, School of Pharmacy, University of Granada, Granada, Spain
Further Information

Publication History

Received: December 10, 2001

Accepted: March 29, 2002

Publication Date:
30 September 2002 (online)

Abstract

The effects of an oral daily dose (20 mg kg-1) of the flavonoid chrysin for 6 weeks in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY) were analysed. Chrysin reduces SHR elevated blood pressure, cardiac hypertrophy and functional vascular changes, but is without effect in WKY. These protective effects were associated with a reduced oxidative status due to the antioxidant properties of the drug.

Abbreviations

MDA:total plasma malondialdehyde

SBP:systolic blood pressure

SHR:spontaneously hypertensive rat

WKY:Wistar Kyoto rat

References

  • 1 Griendling K K, Alexander R W. Oxidative stress and cardiovascular disease.  Circulation. 1997;  96 3264-5
  • 2 Grunfeld S, Hamilton C A, Mesaros S, Mcclain S W, Dominiczak A F, Bohr D F. et al . Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats.  Hypertension. 1995;  26 854-7
  • 3 Berry C, Hamilton C A, Brosnan M J, Magill F G, Berg G A, McMurray J JV. et al . Investigation into the sources of superoxide in human blood vessels. Angiotensin II increases superoxide production in human internal mammary arteries.  Circulation. 2000;  101 2206-12
  • 4 Jameson M, Dai F -X, Lüscher T, Skopec J, Diederich A, Diederich D. Endothelium-derived contracting factors in resistence arteries of young spontaneously hypertensive rats before development of overt hypertension.  Hypertension. 1993;  21 280-8
  • 5 Rice-Evans C A, Miller N J, Paganda G. Structure-antioxidant activity relationships of flavonoids and phenolic acids.  Free Radical Bio Med. 1996;  20 933-56
  • 6 Duarte J, Jiménez R, Villar I C, Pérez-Vizcaino F, Jiménez J, Tamargo J. Vasorelaxant effects of the bioflavonoid chrysin in isolated rat aorta.  Planta Med. 2001;  67 567-9
  • 7 Siess M H, Le Bon A M, Canivenc-Lavier M C, Amiot M J, Sabatier S, Aubert S Y. et al . Flavonoids of honey and propolis: Characterization and effects on hepatic drug-metabolizing enzymes and benzo[α]pyrene-DNA binding in rats.  J Agric Food Chem. 1996;  44 2297-301
  • 8 Walle T, Otake Y, Brubaker J A, Walle U K, Halushka P V. Disposition and metabolism of the flavonoid chrysin in normal volunteers.  Br J Clin Pharmacol. 2001;  51 143-6
  • 9 Morrow J D, Roberts L J. The isoprostanes. Current knowledge and directions for future research.  Biochem Pharmacol. 1996;  51 1-9
  • 10 Frochlich E, Apstein C, Chobanian A, Devereux R, Dustan H, Dzau V. et al . The heart in hypertension.  New Engl J Med. 1993;  327 998-1008
  • 11 Duarte J, Pérez-Palencia R, Vargas F, Ocete M A, Pérez-Vizcaino F, Zarzuelo A. et al . Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats.  Br J Pharmacol. 2001;  133 117-24

Prof. Dr. Juan Duarte

Department of Pharmacology

School of Pharmacy

University of Granada

18071 Granada

Spain

Phone: +34-958243889

Fax: +34-958248964

Email: jmduarte@ugr.es

    >